Cough, Cold and Allergy (Hay Fever) Remedies in Germany
January 10, 2023
Euromonitor
25
PDF
Cough, Cold and Allergy (Hay Fever) Remedies in Germany
Abstract In value share terms, cough, cold and allergy (hay fever) remedies remains the largest OTC category in Germany. The category suffered in 2020 due to changes in lifestyles during the pandemic, as various restrictions to control the spread of COVID-19, including home seclusion, also limited the spread of common viruses such as colds and influenza, whilst reducing consumers’ exposure to allergens. Sales marginally improved in 2021 as colds and flu gradually returned in line with greater mobility as...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Content Cough, Cold and Allergy (Hay Fever) Remedies in Germany January 2023
List Of Contents And Tables
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GERMANY KEY DATA FINDINGS 2022 DEVELOPMENTS Cough, cold and allergy (hay fever) remedies records strong growth due to return of colds and influenza High pollen levels intensify demand for antihistamines/allergy remedies Improving demand for pharyngeal preparations in 2022 PROSPECTS AND OPPORTUNITIES Post-pandemic era likely to see improving demand for cough and cold remedies Herbal/traditional products offer positive outlook Diversification of portfolios as threat of pandemic wanes CATEGORY DATA Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022 Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022 Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022 Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022 Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027 Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027 CONSUMER HEALTH IN GERMANY EXECUTIVE SUMMARY Consumer health in 2022: The big picture 2022 key trends Competitive landscape Retailing developments What next for consumer health? MARKET INDICATORS Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022 Table 8 Life Expectancy at Birth 2017-2022 MARKET DATA Table 9 Sales of Consumer Health by Category: Value 2017-2022 Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022 Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022 Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022 Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022 Table 14 Distribution of Consumer Health by Format: % Value 2017-2022 Table 15 Distribution of Consumer Health by Format and Category: % Value 2022 Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027 Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027 APPENDIX OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches Summary 1 OTC: Switches 2021-2022 DISCLAIMER DEFINITIONS SOURCES Summary 2 Research Sources
In value share terms, cough, cold and allergy (hay fever) remedies remains the largest OTC category in Germany. The category suffered in 2020 due to changes in lifestyles during the pandemic, as various restrictions to control the spread of COVID-19, including home seclusion, also limited the spread of common viruses such as colds and influenza, whilst reducing consumers’ exposure to allergens. Sales marginally improved in 2021 as colds and flu gradually returned in line with greater mobility as...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Cough, Cold and Allergy (Hay Fever) Remedies in Germany January 2023
List Of Contents And Tables
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GERMANY KEY DATA FINDINGS 2022 DEVELOPMENTS Cough, cold and allergy (hay fever) remedies records strong growth due to return of colds and influenza High pollen levels intensify demand for antihistamines/allergy remedies Improving demand for pharyngeal preparations in 2022 PROSPECTS AND OPPORTUNITIES Post-pandemic era likely to see improving demand for cough and cold remedies Herbal/traditional products offer positive outlook Diversification of portfolios as threat of pandemic wanes CATEGORY DATA Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022 Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022 Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022 Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022 Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027 Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027 CONSUMER HEALTH IN GERMANY EXECUTIVE SUMMARY Consumer health in 2022: The big picture 2022 key trends Competitive landscape Retailing developments What next for consumer health? MARKET INDICATORS Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022 Table 8 Life Expectancy at Birth 2017-2022 MARKET DATA Table 9 Sales of Consumer Health by Category: Value 2017-2022 Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022 Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022 Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022 Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022 Table 14 Distribution of Consumer Health by Format: % Value 2017-2022 Table 15 Distribution of Consumer Health by Format and Category: % Value 2022 Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027 Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027 APPENDIX OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches Summary 1 OTC: Switches 2021-2022 DISCLAIMER DEFINITIONS SOURCES Summary 2 Research Sources